The funds will be used to purchase outstanding optionally convertible debentures issued by the company’s subsidiary Biocon ...

The decision comes after receiving approvals from the Board of Directors in April and from shareholders through a postal ...

Shares of Biocon Ltd., surged 1.3% on Tuesday after the company's board of directors approved the floor price for the share ...

The company has set the floor price for the issue at Rs 340.20 per equity share, in line with the pricing formula prescribed ...

Bengaluru-based Biocon Ltd. closes the window to list its arm, Biocon Biologics Ltd., as it raises Rs 4,500 crore to provide ...

Biocon launches Rs 4,500-crore QIP to raise funds for debt repayment, Biocon Biologics investment, and corporate needs ...

Biocon shares will be in focus of stock market investors on Tuesday, 17 June 2025, after the company's board of directors ...

Indian drug companies are preparing to launch low-cost versions of Novo Nordisk’s Wegovy and Ozempic as patents expire in 2026, making weight-loss and diabetes treatment more affordable worldwide.

Biocon has launched a ₹4,500 crore Qualified Institutional Placement, setting the floor price at ₹340.20 per share. Proceeds ...

Biocon Ltd, a global bio-pharmaceutical firm, plans to launch a qualified institutional placement (QIP) soon to raise up to ...

Kiran Mazumdar-Shaw led global bio-pharmaceutical firm Biocon Ltd plans to launch its proposed QIP (qualified institutional ...

The GIFT Nifty was trading 0.02% or 6 points down at 25,004 as of 6:40 a.m., which implied a slight lower open for the ...